Oliver Kacelnik

656 total citations
34 papers, 292 citations indexed

About

Oliver Kacelnik is a scholar working on Infectious Diseases, Modeling and Simulation and Oncology. According to data from OpenAlex, Oliver Kacelnik has authored 34 papers receiving a total of 292 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Infectious Diseases, 11 papers in Modeling and Simulation and 8 papers in Oncology. Recurrent topics in Oliver Kacelnik's work include COVID-19 epidemiological studies (11 papers), Antibiotic Use and Resistance (6 papers) and Bacterial Identification and Susceptibility Testing (6 papers). Oliver Kacelnik is often cited by papers focused on COVID-19 epidemiological studies (11 papers), Antibiotic Use and Resistance (6 papers) and Bacterial Identification and Susceptibility Testing (6 papers). Oliver Kacelnik collaborates with scholars based in Norway, Sweden and United Kingdom. Oliver Kacelnik's co-authors include Kjetil Telle, Silje Bakken Jørgensen, Karin Nygård, Petter Elstrøm, Bjørn G Iversen, Preben Aavitsland, Rannveig Kaldager Hart, Ørjan Samuelsen, Siri Helene Hauge and Margrethe Greve‐Isdahl and has published in prestigious journals such as JAMA, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Oliver Kacelnik

34 papers receiving 279 citations

Peers

Countries citing papers authored by Oliver Kacelnik

Since Specialization

Citations

This map shows the geographic impact of Oliver Kacelnik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oliver Kacelnik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oliver Kacelnik more than expected).

Fields of papers citing papers by Oliver Kacelnik

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Oliver Kacelnik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oliver Kacelnik. The network helps show where Oliver Kacelnik may publish in the future.

Co-authorship network of co-authors of Oliver Kacelnik

This figure shows the co-authorship network connecting the top 25 collaborators of Oliver Kacelnik. A scholar is included among the top collaborators of Oliver Kacelnik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Oliver Kacelnik. Oliver Kacelnik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Patient perspectives on infection prevention and control in cancer care: a survey of knowledge and attitudes among persons with cancer and their next of kin 2024 ·Journal of Hospital Infection ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Michael Borg, Oliver Kacelnik, Jørgen Vildershøj Bjørnholt	1
2	Nationwide, population-based observational study of the molecular epidemiology and temporal trend of carbapenemase-producing Enterobacterales in Norway, 2015 to 2021 2023 ·Eurosurveillance ·Oskar Ljungquist, Bjørg Haldorsen, Anna K. Pöntinen, Jessin Janice, (unknown), Petter Elstrøm, Oliver Kacelnik, (unknown), Arnfinn Sundsfjord, Ørjan Samuelsen	10
3	The population structure of vancomycin-resistant and -susceptible Enterococcus faecium in a low-prevalence antimicrobial resistance setting is highly influenced by circulating global hospital-associated clones 2023 ·Microbial Genomics ·(unknown), Jessin Janice, Jørgen Vildershøj Bjørnholt, Oliver Kacelnik, Bjørg Haldorsen, Randi Nygaard, (unknown), Arnfinn Sundsfjord, Kristin Hegstad, (unknown)	7
4	Intraregional hospital outbreak of OXA-244-producing Escherichia coli ST38 in Norway, 2020 2023 ·Eurosurveillance ·Paul Christoffer Lindemann, Torunn Pedersen, (unknown), Jessin Janice, (unknown), (unknown), (unknown), (unknown), Oliver Kacelnik, Arnfinn Sundsfjord, Ørjan Samuelsen	9
5	A new method for near real-time, nationwide surveillance of nosocomial COVID-19 in Norway: providing data at all levels of the healthcare system, March 2020 to March 2022 2023 ·Eurosurveillance ·(unknown), Silje Bakken Jørgensen, J. Reilly, Oliver Kacelnik	2
6	Clusters of healthcare-associated SARS-CoV-2 infections in Norwegian hospitals detected by a fully automatic register-based surveillance system 2023 ·Journal of Hospital Infection ·(unknown), (unknown), Oliver Kacelnik, (unknown), (unknown), (unknown), (unknown)	3
7	The epidemiology of multidrug-resistant organisms in persons diagnosed with cancer in Norway, 2008–2018: expanding surveillance using existing laboratory and register data 2023 ·European Journal of Clinical Microbiology & Infectious Diseases ·(unknown), Petter Elstrøm, (unknown), Solveig Hofvind, David W. Eyre, Oliver Kacelnik, Jørgen Vildershøj Bjørnholt	2
8	Pseudomonas aeruginosa countrywide outbreak in hospitals linked to pre-moistened non-sterile washcloths, Norway, October 2021 to April 2022 2022 ·Eurosurveillance ·Kirsten Gravningen, Oliver Kacelnik, Egil Lingaas, Torunn Pedersen, Bjørn G Iversen, (unknown)	10
9	A new automated national register-based surveillance system for outbreaks in long-term care facilities in Norway detected three times more severe acute respiratory coronavirus virus 2 (SARS-CoV-2) clusters than traditional methods 2022 ·Infection Control and Hospital Epidemiology ·Kirsten Gravningen, (unknown), Torgeir Bruun Wyller, Oliver Kacelnik	2
10	Transmission of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) between hospital workers and members of their household: Nationwide, registry-based, cohort study from Norway 2022 ·Infection Control and Hospital Epidemiology ·(unknown), Kjetil Telle, Petter Elstrøm, (unknown), Oliver Kacelnik	5
11	High vaccine effectiveness against coronavirus disease 2019 (COVID-19) and severe disease among residents and staff of long-term care facilities in Norway, November 2020–June 2021 2022 ·SHILAP Revista de lepidopterología ·Jostein Starrfelt, (unknown), Oliver Kacelnik, (unknown), Elina Seppälä, Hinta Meijerink	6
12	Clinical outcomes of antimicrobial resistance in cancer patients: A systematic review of multivariable models 2022 ·medRxiv ·(unknown), (unknown), (unknown), Anders Eivind Myhre, (unknown), Oliver Kacelnik, Jørgen Vildershøj Bjørnholt	1
13	A step forward in antibiotic use and resistance monitoring: a quarterly surveillance system pilot in 11 European Union/European Economic Area countries, September 2017 to May 2020 2022 ·Eurosurveillance ·Germán Peñalva, (unknown), (unknown), (unknown), Oliver Kacelnik, José Miguel Cisneros, (unknown)	5
14	Risk factors, immune response and whole‐genome sequencing of SARS‐CoV‐2 in a cruise ship outbreak in Norway 2022 ·International Journal of Infectious Diseases ·Kirsten Gravningen, (unknown), Olav Hungnes, Kristian Svendsen, Emily MacDonald, Henrik Schirmer, Kathrine Stene‐Johansen, Gunnar Skov Simonsen, Oliver Kacelnik, Petter Elstrøm, Karoline Bragstad, Christine Hanssen Rinaldo	5
15	Transmission of SARS-CoV-2 into and within immigrant households: nationwide registry study from Norway 2021 ·Journal of Epidemiology & Community Health ·(unknown), Rannveig Kaldager Hart, Anna Godøy, Silje Bakken Jørgensen, Oliver Kacelnik, Kjetil Telle	8
16	Birthing parents had a lower risk of testing positive for SARS-CoV-2 in the peripartum period in Norway, 15th of February 2020 to 15th of May 2021 2021 ·Infection Prevention in Practice ·(unknown), (unknown), Maria C. Magnus, Kirsten Gravningen, (unknown), Oliver Kacelnik	1
17	The fight to keep resistance at bay, epidemiology of carbapenemase producing organisms (CPOs), vancomycin resistant enterococci (VRE) and methicillin resistant Staphylococcus aureus (MRSA) in Norway, 2006 - 2017 2019 ·PLoS ONE ·Petter Elstrøm, (unknown), Kristin Hegstad, Ørjan Samuelsen, (unknown), Oliver Kacelnik	22
18	Financial and temporal costs of patient isolation in Norwegian hospitals 2019 ·Journal of Hospital Infection ·(unknown), Petter Elstrøm, Oliver Kacelnik, (unknown), Torbjørn Wisløff, Birgitte Freiesleben de Blasio	4
19	Is It Valid to Compare Surgical Site Infections Rates Between Countries? Insights From a Study of English and Norwegian Surveillance Systems 2016 ·Infection Control and Hospital Epidemiology ·Hinta Meijerink, Theresa Lamagni, Hanne Merete Eriksen, Suzanne Elgohari, Pauline Harrington, Oliver Kacelnik	4
20	Guidelines for Antibiotic Prophylaxis of Cholecystectomies in Norwegian Hospitals 2013 ·Surgical Infections ·Oliver Kacelnik, (unknown), Odd Mjåland, Hanne Merete Eriksen, Finn Egil Skjeldestad	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact